Cathay International Holdings Limited announced that its subsidiary Lansen Pharmaceutical Holdings Co. Ltd. (Lansen) has announced that it has received notice from Mr. Xu Jun (Mr. Xu, an executive director of Lansen and the chief executive officer of the Lansen group) that he will not renew his service contract, expiring on April 8, 2013, due to personal reasons. Upon expiry of his service contract, Mr. Xu will no longer serve as the executive director of Lansen.

Mr. Xu has confirmed that he has no disagreement with the board of Lansen and there is no matter that needs to be brought to the attention of the shareholders of Lansen. Mr. Xu has confirmed that he has no disagreement with the board of Lansen and there is no matter that needs to be brought to the attention of the shareholders of Lansen. Lansen at the same time announced that Mr. Liu Bang Min (Mr. Liu) will be appointed as the executive director of Lansen with effect from April 9, 2013.

Mr. Liu Bang Min, age 41, is the senior vice president of sales and general manager of both Lansen Medicine (Shenzhen) Company Limited and Ningbo Lansen Pharmaceutical Company Limited, both wholly owned subsidiaries of the Lansen group, and is responsible for the marketing and management of the Lansen group. Mr. Liu joined the Lansen Group in September 2012. He has over 17 years of experience in the pharmaceutical industry.

Prior to joining Group, Mr. Liu had been the national sales director (Rheumatology Group) of Abbott China from 2009 to 2011.